Last 11 quarters of trend data · Healthcare · Medical - Diagnostics & Research
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -11.93 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 38.65 | 16.47 | 12.87 | 19.99 | 14.75 | 12.68 | 6.88 | 3.72 | 3.83 | 3.73 | — | — |
| — | +29.9% | +87.1% | +437.1% | +285.5% | +239.7% | — | — | — | — | — | — | |
| P/B Ratio | 1.89 | 1.16 | 0.84 | 1.35 | 0.95 | 0.78 | 0.36 | 0.23 | 0.17 | 0.18 | — | — |
| — | +48.6% | +131.4% | +494.5% | +462.5% | +339.8% | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -42.5% | -28.1% | 47.9% | -25.5% | -37.9% | -50.0% | -62.6% | -41.7% | -77.6% | -56.0% | -82.0% | -61.5% |
| — | +43.8% | +176.5% | +38.8% | +51.1% | +10.7% | +23.7% | +32.1% | — | — | — | — | |
| Operating Margin | -363.0% | -388.9% | -332.9% | -285.4% | -346.2% | -446.9% | -482.5% | -358.0% | -640.5% | -5133.8% | -851.1% | -641.7% |
| — | +13.0% | +31.0% | +20.3% | +46.0% | +91.3% | +43.3% | +44.2% | — | — | — | — | |
| Net Margin | -277.5% | -246.7% | -228.5% | -227.5% | -245.8% | -320.7% | -333.6% | -253.8% | -438.7% | -4958.8% | -819.3% | -18.1% |
| — | +23.1% | +31.5% | +10.4% | +44.0% | +93.5% | +59.3% | -1300.7% | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -16.1% | -4.4% | -3.7% | -4.1% | -3.9% | -4.8% | -4.3% | -3.8% | -4.8% | -47.4% | -5.7% | -0.2% |
| — | +9.3% | +15.1% | -8.0% | +17.9% | +89.8% | +24.6% | -2430.3% | — | — | — | — | |
| ROA | -13.8% | -3.9% | -3.3% | -3.6% | -3.4% | -4.1% | -3.6% | -3.2% | -3.9% | -39.6% | -4.7% | -0.1% |
| — | +4.9% | +10.6% | -12.9% | +14.7% | +89.6% | +22.6% | -2538.3% | — | — | — | — | |
| ROIC | -16.8% | -5.2% | -4.1% | -4.1% | -4.3% | -5.2% | -4.9% | -4.9% | -7.6% | -50.1% | -5.1% | -4.0% |
| — | +0.7% | +15.3% | +17.7% | +44.1% | +89.7% | +3.3% | -22.8% | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| — | +33.7% | -23.4% | +39.7% | -6.2% | -4.9% | +33.0% | +17.6% | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 11.97 | 10.95 | 11.74 | 11.97 | 7.61 | 9.23 | 9.71 | 10.66 | 9.65 | 11.55 | 9.65 | 0.95 |
| — | +18.7% | +21.0% | +12.3% | -21.1% | -20.1% | +0.6% | +1017.3% | — | — | — | — | |
| Quick Ratio | 11.77 | 10.74 | 11.51 | 11.77 | 7.37 | 8.95 | 9.46 | 10.42 | 9.43 | 11.26 | 9.45 | 0.82 |
| — | +20.0% | +21.8% | +13.0% | -21.8% | -20.6% | +0.1% | +1168.2% | — | — | — | — | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 11 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GRAL stock.
GRAIL Inc.'s current P/E is -11.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
GRAIL Inc.'s current operating margin is -363.0%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking GRAIL Inc.'s business trajectory between earnings reports.